Nxera Pharma Co., Ltd.
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-03-25
Nxera Pharma Co., Ltd.
Equibles does not estimate personal net worth.
David Roblin has spoken on 1 investor event across 1 company, most recently for Nxera Pharma Co., Ltd. on March 25, 2026. Nxera Pharma Co., Ltd. is classified in the Biotechnology industry within the Healthcare sector.
“I'm a medical doctor, and I've been practicing in research and development for new medicines for 30 years, and I've had the privilege and honor of developing 11 medicines in my career to date with Pfizer, Bayer, and in biotech.”
Nxera Pharma Co., Ltd.
Transcript header (unverified)
Nxera Pharma Co., Ltd.
Biotechnology · Healthcare
36th Ordinary General Meeting of Shareholders
Nxera Pharma Co., Ltd.